Chairat Supsamutchai
Bangkok, Bankok, 10400, Thailand
NCT Number: NCT04334395
In asymptomatic Stage 4 colorectal cancer, the treatment varies between many hospitals and countries. Some studies found that primary tumor resection had better survival rates and a lower risk of mortality. But many studies found significant benefits in survival in sub groups of the population such as age less than 70 years, WHO performance status <2, no extra-hepatic metastasis, liver tumor burden <50%. However some studies showed no survival benefits in primary tumor resection. So this study will focus on survival, adverse events, complications in primary tumor resection and no primary tumor resection in asymptomatic Stage 4 colorectal cancer.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bangkok, Bankok, 10400, Thailand
The retrospective study of patients in asymptomatic Stage 4 colorectal cancer received treatment at Ramathibodi Hospital and excluded symptomatic primary tumors such as obstruction, perforation that required surgery, carcinomatosis peritoneii, and patients with secondary cancer diagnosis in the past 5 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
resection of cancer at colon
Time frame: 5 year
The definition of complication defined as symptom that occurred during treatment period such as obstruction , perforation , bleeding , trenesmus.
Time frame: 5 year
The survival time defined as time from diagnosis to death or last follow up period
Mahidol University
Other
A Retrospective Cohort Study Outcome of Treatment in Asymptomatic Stage 4 Colorectal Cancer : Primary Tumor Resection vs. No Primary Tumor Resection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00826540
Colonic Diseases, Colonic Neoplasms
Scottsdale, Arizona, United States
View Trial DetailsNCT01814501
Colonic Diseases, Colonic Neoplasms
Columbus, Ohio, United States
View Trial DetailsNCT01652196
Colonic Diseases, Colonic Neoplasms
Ann Arbor, Michigan, United States
View Trial DetailsNCT03154190
Acute Myeloid Leukemia, Adenocarcinoma
Fullerton, California, United States
View Trial Details